23 min
Australian Biotech Open for Business at BIO 2022 The MTPConnect Podcast
-
- Science
As the world’s largest Biotech convention, BIO 2022, gets underway in San Diego California after a 2 year hiatus due to pandemic restrictions, MTPConnect’s team is on the ground promoting Australian companies at the Australian Pavilion (led by AusBiotech) and attending various events and meetings. In this pacey compilation, MTPConnect CEO Stuart Dignam catches up with the Hon. Stephen Dawson MLC, WA’s Minister for Innovation, ICT and Medical Research on the WA Mission to the US. Stuart talks with ARIA Research CEO and Co-founder Robert Yearsley about the opportunities for connecting at BIO 2022 for their medtech venture. Argenica Therapeutics MD and CEO Dr Liz Dallimore from WA highlights opportunities to meet investors and potential partners as the company moves its novel drug candidate, a neuroprotective therapeutic, towards commercialisation. Distinguished Professor Lyn Griffiths from QUT and Director of the Bridge Program, is in San Diego with nine Australian pitch winners from the Bridge Program (which equips researchers and entrepreneurs with the knowledge, skills and networks needed to commercialise new pharmaceuticals) who are visiting multinational pharma companies. And finally, Stuart wraps up with a final word from Australia’s Ambassador to the USA, Hon. Arthur Sinodinos AO, about Australia being open for business and in the sights of US industry.
As the world’s largest Biotech convention, BIO 2022, gets underway in San Diego California after a 2 year hiatus due to pandemic restrictions, MTPConnect’s team is on the ground promoting Australian companies at the Australian Pavilion (led by AusBiotech) and attending various events and meetings. In this pacey compilation, MTPConnect CEO Stuart Dignam catches up with the Hon. Stephen Dawson MLC, WA’s Minister for Innovation, ICT and Medical Research on the WA Mission to the US. Stuart talks with ARIA Research CEO and Co-founder Robert Yearsley about the opportunities for connecting at BIO 2022 for their medtech venture. Argenica Therapeutics MD and CEO Dr Liz Dallimore from WA highlights opportunities to meet investors and potential partners as the company moves its novel drug candidate, a neuroprotective therapeutic, towards commercialisation. Distinguished Professor Lyn Griffiths from QUT and Director of the Bridge Program, is in San Diego with nine Australian pitch winners from the Bridge Program (which equips researchers and entrepreneurs with the knowledge, skills and networks needed to commercialise new pharmaceuticals) who are visiting multinational pharma companies. And finally, Stuart wraps up with a final word from Australia’s Ambassador to the USA, Hon. Arthur Sinodinos AO, about Australia being open for business and in the sights of US industry.
23 min